SHANNON WILLIAMS: Open Payments
NPI 1902379738 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 22 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $141 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $156 |
| Janssen Pharmaceuticals, Inc | 2 | $118 |
| Vanda Pharmaceuticals Inc. | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: ARISTADA, CAPLYTA, SPRAVATO, FANAPT, INGREZZA, REXULTI, VRAYLAR, UZEDY.
Industry payments across VA — which companies pay providers there.
